Our company
Overview
Our Strategy
Senior leadership team
Board of Directors
Scientific board
Careers
Events
Certifications
Technology
What are Autoantibodies ?
ImmunoINSIGHTS Platform
Publications
Biotech/Pharma
Biomarker Discovery
Targeted Panels & Arrays
Bioinformatics & Data Science
Applications
Autoimmune Disease Biomarkers
Immuno-Oncology Biomarkers
Infectious Disease Biomarkers
Resources
Investors
Overview
Regulatory news
Share price
Analyst research
Results, reports & presentations
Shareholder analysis
Company documents
Corporate governance
NOMAD & advisor contacts
Contact us
Resources
Therapeutic areas
All
Autoimmune diseases
General
Immuno-oncology
Infectious diseases
Partnerships
Uncategorised
Diseases
Systemic lupus erythematosus (SLE)
Sjörgen’s syndrome
Systemic sclerosis (SSc)
Rheumatoid arthritis (RA)
Checkpoint inhibitors
Bispecifics
CAR-T
CART-NK
EarlyCDT Lung Cancer
COVID19
Long-Covid
Filter by type
autoantibodies
Brochure
cancer
checkpoint inhibitors
Company News
Diagnostics
earlyCDT
ecls
immunotheraphies
Indeterminate Pulmonary Nodules
Lung Cancer
Poster
Publication
Webinar
Oncimmune to participate at the ASCO 2023 Meeting
Read Article
Siemens Healthineers and Oncimmune partner to improve malignancy risk assessment of indeterminate pulmonary nodules (IPNs)
Read Article
16 August 2022
16 August 2022
4 August 2022
4 August 2022
29 July 2022
21 April 2022
8 April 2022
7 March 2022
4 March 2022
1 March 2022
